REGISTERED NUMBER: 13388311 (England and Wales)

FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

FOR

KP MEDICS LIMITED

Page

Balance Sheet

1

FIXED ASSETS

-

15

CURRENT ASSETS

106,889

86,296

CREDITORS

Amounts falling due within one year

(23,673

)

(24,275

)

NET CURRENT ASSETS

83,216

62,021

TOTAL ASSETS LESS CURRENT LIABILITIES

83,216

62,036

CAPITAL AND RESERVES

83,216

62,036

NOTES TO THE FINANCIAL STATEMENTS

1.	STATUTORY INFORMATION

KP Medics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number:

13388311

Registered office:

77 Cecil Avenue

Wembley

Middlesex

HA9 7DY

The presentation currency of the financial statements is the Pound Sterling (£).

2.	AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 1 (2024 - 1 ) .

3.	DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

At the year ended 31 March 2025, £17,984 (2024 - £13,043) was due to the director of the company. During the period, dividends totalling £500 was paid to the director.

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 6 December 2025 and were signed by:

Dr K Patel - Director